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Effect of Lipid-based Nutrient Supplement - Medium Quantity
on Reduction of Stunting in Children 6–23 Months of Age in Sindh,
Pakistan: A Cluster Randomized Controlled Trial (OR25-06-19)
Sajid Soofi,1 Gul Nawaz,1 and Cecilia Garzon2
1Aga Khan University; and 2World Food Program
Objectives: We evaluated the effectiveness of a locally produced
lipid-based nutrient supplement - medium-quantity (LNS-MQ) known
as Wawamum to prevent stunting in children 6–23 months of age in
Thatta and Sujawal districts of Sindh province, Pakistan.
Methods: A cluster randomized controlled trial was conducted and
a total of 870 children between 6–18months oldwere enrolled. Children
in the intervention group received 50 grams/day of Wawamum for
6 months, while children in the control group received standard
government health services, not including Wawamum. The primary
outcome was stunting risk reduction among children 6–23 months of
age.
Results: Children who received Wawamum were found to have
a significantly reduced risk of stunting (RR = 0.91, 95% CI; 0.88–
0.94, P < 0.001) and wasting (RR = 0.78, 95% CI; 0.67–0.92, p-
0.004) as compared to children who received the standard government
health services. A non-significant impact was observed on underweight
(RR = 0.94, 95% CI; 0.85–1.04, p-0.241) in the intervention group
compared to the control group. Statistically significant reduction in
anaemia in the intervention group was also found as compared to the
control group (RR = 0.97, 95% CI; 0.94–0.99, p-0.008). The reduction
in risk of severe anaemia was even more evident (RR = 0.45, 95% CI;
0.28–0.99, p-0.002) in the intervention group than in the control group.
The mean compliance of Wawamum was 60.3% among children.
Conclusions: The study confirmed the plausibility of achieving
nutrition gains in the short-term with a locally produced LNS-MQ,
known as Wawamum, through the primary health care system. The
risk of stunting and wasting was reduced by 9% and 22%, respectively.
The statistically significant reduction in risk of stunting, wasting and
anaemia among children 6–23months of age showed that an immediate
improvement in these nutrition indicators is indeed possible. This
approach can be scaled up in similar settings to achieve positive
outcomes for nutrition and health.
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